You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search
Drug Formulary
About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and updated drug and regimen monographs, patient information sheets, as well as safety and advice documents added to the Drug Formulary within the last 30 days are available here.

Regimen

Published Date: 09 Apr 2018

Revision Summary: Updated supplementary public funding section
Updated
Apr 2018
Drug

Published Date: 09 Apr 2018

Revision Summary: Updated Supplementary public funding section
Updated
Apr 2018
Regimen

Published Date: 06 Apr 2018

Revision Summary: updated capecitabine funding to general benefit
Updated
Apr 2018
Regimen

Published Date: 06 Apr 2018

Revision Summary: Updated capecitabine funding to ODB-General Benefit.
Updated
Apr 2018
Regimen

Published Date: 06 Apr 2018

Revision Summary: Updated dosing section based on Gyne disease group feedback
Updated
Apr 2018
Regimen

Published Date: 06 Apr 2018

Revision Summary: Updated dosing section based on Gyne disease site feedback
New
Apr 2018
Regimen

Published Date: 06 Apr 2018

Revision Summary: oxaliplatin funded by ST-QBP (removed unfunded flag); updated capecitabine funding to general benefit
Updated
Apr 2018
Regimen

Published Date: 06 Apr 2018

Revision Summary: updated dosing section based on Gyne disease site group feedback
Updated
Apr 2018
Regimen

Published Date: 06 Apr 2018

Revision Summary: oxaliplatin funded by ST-QBP (removed unfunded flag)
Updated
Apr 2018
Regimen

Published Date: 06 Apr 2018

Revision Summary: oxaliplatin funded by ST-QBP (removed unfunded flag)
Updated
Apr 2018
Regimen

Published Date: 06 Apr 2018

Revision Summary: Updated dosing and cycle frequency sections based on Gyne disease site group feedback
Updated
Apr 2018
Regimen

Published Date: 06 Apr 2018

Revision Summary: Newly approved ST-QBP regimen.
New
Apr 2018